LONDON-Covington advised Draig Therapeutics Limited on its $140m financing since inception of the company in 2024.
Draig Therapeutics is developing novel treatment options for neuropsychiatric disorders and was co-founded by Cardiff University and SV Health Investors, which led the seed financing with ICG. The oversubscribed Series A financing was led by Access Biotechnology, with participation from Canaan Partners, SR One, Sanofi Ventures, Schroders Capital along with seed investors.
The Covington team was led by Ben Land-Maycock and Katy Knight.
LEGAL DESIRE NEWSLETTER
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.